Skip to Content

Nanobac Pharmaceuticals Inc NNBP

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Nanobac Pharmaceuticals Inc is a research-based, bio-lifescience company. The Company is primarily engaged in the discovery and development of products and services to improve peoples health through the detection and treatment of Calcifying Nanoparticles.

Contact
5025 West Lemon Street
Tampa, FL, 33609
T +1 813 865-1125
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Dec 31, 2007
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 10